Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 What does the future hold for chemotherapy with the use of lipid-based nanocarriers?

Literature DB >> 31872773

What does the future hold for chemotherapy with the use of lipid-based nanocarriers?

Carlotta Pucci¹, Chiara Martinelli¹, Gianni Ciofani¹.

Abstract

Entities: Chemical Disease Gene Species

Keywords: cancer therapy; chemotherapeutics; clinical trials; lipid nanocarriers; nanomedicine

Mesh：

Substances：
Drug Carriers
Lipids

Year: 2019 PMID： 31872773 PMCID： PMC7025883 DOI： 10.2217/fon-2019-0767

Source DB: PubMed Journal: Future Oncol ISSN： 1479-6694 Impact factor: 3.404

Keyword Cloud
References

× No keyword cloud information.

18 in total

1. Stimulus-responsive liposomes as smart nanoplatforms for drug delivery applications.

Authors: Parham Sahandi Zangabad; Soroush Mirkiani; Shayan Shahsavari; Behrad Masoudi; Maryam Masroor; Hamid Hamed; Zahra Jafari; Yasamin Davatgaran Taghipour; Hura Hashemi; Mahdi Karimi; Michael R Hamblin
Journal: Nanotechnol Rev Date: 2017-12-12 Impact factor: 7.848

2. Triggered release of paclitaxel from magnetic solid lipid nanoparticles by magnetic hyperthermia.

Authors: Relton Romeis Oliveira; Marcus S Carrião; Maiulle Teixeira Pacheco; Luis Cesar Branquinho; Ana Luiza R de Souza; Andris F Bakuzis; Eliana M Lima
Journal: Mater Sci Eng C Mater Biol Appl Date: 2018-07-05 Impact factor: 7.328

3. Docetaxel-loaded nanostructured lipid carriers functionalized with trastuzumab (Herceptin) for HER2-positive breast cancer cells.

Authors: Jaleh Varshosaz; Mohammad Ali Davoudi; Sara Rasoul-Amini
Journal: J Liposome Res Date: 2017-09-06 Impact factor: 3.648

10. Nanostructured lipid carriers co-delivering lapachone and doxorubicin for overcoming multidrug resistance in breast cancer therapy.

Authors: Xin Li; Xiaoqian Jia; Hu Niu
Journal: Int J Nanomedicine Date: 2018-07-12

What does the future hold for chemotherapy with the use of lipid-based nanocarriers?

1. Stimulus-responsive liposomes as smart nanoplatforms for drug delivery applications.

2. Triggered release of paclitaxel from magnetic solid lipid nanoparticles by magnetic hyperthermia.

3. Docetaxel-loaded nanostructured lipid carriers functionalized with trastuzumab (Herceptin) for HER2-positive breast cancer cells.

Review 4. Cancer nanomedicine: progress, challenges and opportunities.

Review 5. Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic.

Review 6. Lipid Nanovectors to Deliver RNA Oligonucleotides in Cancer.

7. Near-Infrared Activated Release of Doxorubicin from Plasmon Resonant Liposomes.

8. Innovative approaches for cancer treatment: current perspectives and new challenges.

9. Stealth properties to improve therapeutic efficacy of drug nanocarriers.

10. Nanostructured lipid carriers co-delivering lapachone and doxorubicin for overcoming multidrug resistance in breast cancer therapy.